Literature DB >> 33415048

Lactobacillus-Associated Spontaneous Bacterial Peritonitis in a Liver Cirrhosis Patient on Probiotics.

Lintu Ramachandran1, Venkata S Dontaraju1, Kushal Patel1.   

Abstract

The efficacy of over the counter probiotics has been an area of scientific debate. While the benefits of probiotics are heavily disputed, probiotics are considered generally safe. We present a case of a liver cirrhosis patient, who presented with hepatic encephalopathy. The patient was taking daily probiotics and receiving weekly therapeutic paracentesis. His workup revealed spontaneous bacterial peritonitis (SBP). Despite starting the patient on empiric ceftriaxone and vancomycin, the patient's leukocytosis did not improve. The paracentesis fluid and blood cultures grew Lactobacillus gasseri. Antibiotics were switched to piperacillin/tazobactam, after which the patient improved clinically. The case highlights the importance of vigilance in using probiotics, especially in liver cirrhosis patients. Also, patients with Lactobacillus-associated SBP may not improve with empiric antibiotic treatment of cephalosporins.
Copyright © 2020, Ramachandran et al.

Entities:  

Keywords:  lactobacillus; liver cirrhosis; paracentesis; probiotics; sbp; spontaneous bacterial peritonitis

Year:  2020        PMID: 33415048      PMCID: PMC7781884          DOI: 10.7759/cureus.11896

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  9 in total

Review 1.  Probiotics for patients with hepatic encephalopathy.

Authors:  Richard G McGee; Anouk Bakens; Kerrie Wiley; Stephen M Riordan; Angela C Webster
Journal:  Cochrane Database Syst Rev       Date:  2011-11-09

2.  Probiotics can treat hepatic encephalopathy.

Authors:  S F Solga
Journal:  Med Hypotheses       Date:  2003-08       Impact factor: 1.538

3.  Antibiotic susceptibility of Lactobacillus and Bifidobacterium species from the human gastrointestinal tract.

Authors:  Susana Delgado; Ana Belén Flórez; Baltasar Mayo
Journal:  Curr Microbiol       Date:  2005-03-15       Impact factor: 2.188

4.  Secondary prophylaxis of hepatic encephalopathy in cirrhosis: an open-label, randomized controlled trial of lactulose, probiotics, and no therapy.

Authors:  Amit Agrawal; Barjesh Chander Sharma; Praveen Sharma; Shiv Kumar Sarin
Journal:  Am J Gastroenterol       Date:  2012-06-19       Impact factor: 10.864

5.  Lactobacillus bacteremia, species identification, and antimicrobial susceptibility of 85 blood isolates.

Authors:  M K Salminen; H Rautelin; S Tynkkynen; T Poussa; M Saxelin; V Valtonen; A Järvinen
Journal:  Clin Infect Dis       Date:  2006-01-25       Impact factor: 9.079

6.  Failure of Lactobacillus spp. to prevent bacterial translocation in a rat model of experimental cirrhosis.

Authors:  Tilman Martin Bauer; Javier Fernández; Miquel Navasa; Jordi Vila; Juan Rodés
Journal:  J Hepatol       Date:  2002-04       Impact factor: 25.083

7.  Achieving High Yield of Lactic Acid for Antimicrobial Characterization in Cephalosporin-Resistant Lactobacillus by the Co-Expression of the Phosphofructokinase and Glucokinase.

Authors:  Yahui Gong; Tiyuan Li; Shiyu Li; Zhenyou Jiang; Yan Yang; Junli Huang; Zhaobing Liu; Hanxiao Sun
Journal:  J Microbiol Biotechnol       Date:  2016-06-28       Impact factor: 2.351

8.  Probiotic yogurt for the treatment of minimal hepatic encephalopathy.

Authors:  Jasmohan S Bajaj; Kia Saeian; Kenneth M Christensen; Muhammad Hafeezullah; Rajiv R Varma; Jose Franco; Joan A Pleuss; Glenn Krakower; Raymond G Hoffmann; David G Binion
Journal:  Am J Gastroenterol       Date:  2008-07       Impact factor: 10.864

Review 9.  Effect of probiotics supplementation on bone mineral content and bone mass density.

Authors:  Kolsoom Parvaneh; Rosita Jamaluddin; Golgis Karimi; Reza Erfani
Journal:  ScientificWorldJournal       Date:  2014-01-22
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.